Navigation Links
Worldwide HCV Performance Panel

ProductsWorldwide HCV Performance Panel
Company BBI Diagnostics
Item Worldwide HCV Performance Panel
Features 
  • Challenges HCV test systems that monitor various stages of infection with genotypes 1, 2, 3, 4, 5, and 6 from geographically diverse areas.
  • Extensive data sheets provides the results of assays for diagnostic, HCV genotype, quantitative RNA, Ag, RIBA and line probe confirmatory, and EIA screening.
  • The panel is a useful tool for design, development, and commercialization comparisons of new anti-HCV assays.
  • Convenient 0.5 ml packaging size.
Description The Anti-HCV Mixed Titer Performance Panel consists of plasma specimens with reactivity ranging from weak to strong positive for antibodies to the Hepatitis C Virus.

This Panel is intended for use by diagnostic manufacturers and clinical laboratories to evaluate their anti-HCV and RNA assays. Comprehensive data from all major test systems are included for comparative analysis on the well-characterized specimens.

Info BBI Diagnostics
Customer Service: 800 676 1881

Related medicine products :

1. Micromax High Performance Instrument System
2. Micromax Plus High Performance Instrument System
3. Emax High Performance Instrument System
4. Performance - Total Knee System
5. Blind Performance Specimens
6. High Performance HME with Port
7. High Performance HME
8. MaxiCompressor™ High Performance 50 PSI Compressor
9. Agarose, separation > 500 bp, Genetic Performance Certified †
10. Agarose - Separation >500 bp Genetic Performance Certified™
11. Anti-HTLV Mixed Titer Performance Panel
Premier Thumb Spica
FREEDOM® Memory Thumb Spica
QualCraft™ Gamekeeper Thumb Stabilizer
...dom® CMC ThumbFit™ reduces joint instabi...ofile splint is remarkably comfortable and easy fo... CHT and Robert V. Sypher Jr., MD, FAAOS, develope...plaints of discomfort and impaired hand function f...
Medicine Products:
(Date:12/3/2009)...wswire/ -- Chiltern International Limited (Chilter...providing clinical development and staffing servic...es the appointment of Dr. Sharon Moore as Execut...ffairs. Dr. Moore is based at Chiltern,s Bristol, ...ian with 15 years of industry experience. Prior to...
(Date:12/3/2009)...ec. 3 For California,s 3.4 million...lity remains one of the most significant threats t...t also their business,s viability. ,, "As the ...l, owners of small businesses are recognizing the ...nhanced disability coverage," said Michael Hagedo...
(Date:12/3/2009)...to an understanding of how accurate DNA replicatio...ancer and genetic diseases ,, DETROIT, Dec. 3 ... have for the first time observed the movement of ...ates nucleotides one by one. More significantly, t... they speculate is part of the proofreading proces...
(Date:12/3/2009)...ocedures on young women caused by outdated HPV tes...on December 11 for blocking new technology. , ... 2, 2009 -- Now the American College of Obstetric...sive cancer workup procedure, also known as colpo...o some women who have received the procedure . How...
(Date:12/3/2009)...ewswire/ -- According to the World Health Organiza...lu") has reached a pandemic level. Over 500,000 c...,500 fatalities. Since there is no longer a requi...numbers undoubtedly understate the real situation....prnh/20091203/NY20654 ) ,, There are currently...
Breaking Medicine News(10 mins):Health News:Chiltern Names Dr. Sharon Moore as Executive VP, Global Quality & Medical Affairs 2Health News:New Disability Income Insurance Options Provide More Choice for California's Small Business Owners 2Health News:New Disability Income Insurance Options Provide More Choice for California's Small Business Owners 3Health News:New Disability Income Insurance Options Provide More Choice for California's Small Business Owners 4Health News:Wayne State Researchers Report a Possible 'Proofreading' Step in DNA Synthesis by Observing Single Molecules of DNA Polymerase 2Health News:Wayne State Researchers Report a Possible 'Proofreading' Step in DNA Synthesis by Observing Single Molecules of DNA Polymerase 3Health News:Harmful Procedures on Young Women Caused by Outdated HPV test, not by Pap Test 2Health News:Buchang Global Health Forum 2009: An Innovative Approach for Management of H1N1 Swine Flu 2
...onetics Europe, BRAINTREE, Mass., Nov. 8 Haemone...l Gordon will join the company,effective November ...ordon,will have responsibility for European operat...and. He will also join,Haemonetics, global Operati...
...-FirstCall/ -- China Sky One,Medical, Inc. (OTC Bu...distributor of pharmaceutical, medicinal and diagn...s completed the previously announced amendment to,...ded September 30, 2007, management determined that...
...VES, RANCHO CORDOVA, Calif., Nov. 8 ThermoGenesi...novative products and,services that process, store...ells for treatment of disease and injury, today re...4.3 million for the first quarter of fiscal,2007. ...
...stribution Channels, OWINGS MILLS, Md., Nov. 8 M...quarter results for the period ended,September 30,...ast reported,revenue of $21.8 million, an 11% incr... versus $1,455,000 or $0.11 per basic,share ($0.11...
...troke and heart attacks, revised label warns , ...S. Food and Drug Administration on Thursday approv...iesis-stimulating agents, which are drugs used to ...ts with chronic kidney failure. Those dangers incl...
... ),announced today that it will present at the Cre...uesday, November 13, 2007 at 11:00 a.m. Eastern,Ti... Senior Vice President,Wyeth and President, Wyeth ... the conference. Wyeth is one of the world,s larg...
Other Medicine News:Health News:Haemonetics Appoints Executive Leadership of European Operations 2Health News:China Sky One Medical Completes Previously Announced Amendment to 2006 Form 10KSB 2Health News:ThermoGenesis Corp. Reports First Quarter 2008 Results 2Health News:ThermoGenesis Corp. Reports First Quarter 2008 Results 3Health News:ThermoGenesis Corp. Reports First Quarter 2008 Results 4Health News:ThermoGenesis Corp. Reports First Quarter 2008 Results 5Health News:ThermoGenesis Corp. Reports First Quarter 2008 Results 6Health News:ThermoGenesis Corp. Reports First Quarter 2008 Results 7Health News:Medifast Announces Third-Quarter 2007 Results 2Health News:Medifast Announces Third-Quarter 2007 Results 3Health News:Medifast Announces Third-Quarter 2007 Results 4Health News:Medifast Announces Third-Quarter 2007 Results 5Health News:Medifast Announces Third-Quarter 2007 Results 6Health News:Medifast Announces Third-Quarter 2007 Results 7Health News:Medifast Announces Third-Quarter 2007 Results 8Health News:FDA Issues New Warnings for Anemia Drugs 2Health News:FDA Issues New Warnings for Anemia Drugs 3
(Date:12/3/2009)..., HOERSHOLM, Denmark and SAN DIEGO, Californ...9 Successfully Inhibits miR-122, a microRNA Import...nificantly Reducing Hepatitis C,Virus in the Blood...e,Hepatitis C Virus , - SPC3649 Demonstra...and,No Serious Adverse Events in the Treated Anima...
(Date:12/3/2009)...MESA, Calif., Dec. 3 TROY Group, ...ing Solutions, announces the addition of the TROY...rescription printing solutions. Based on the HP La...5 SecureRx(TM) Printers provide a fast 42 page per...printing capability and enhanced TROY prescription...
(Date:12/3/2009)...UL, Minn., Dec. 3 Apnex Medical, I...hat it has completed a second round of private equ... be used to complete a clinical study and develop ... technology designed to treat obstructive sleep ap...lude Domain Associates, New Enterprise Associates ...
Breaking Medicine Technology:New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 2New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 4New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 5New TROY SecureRx Prescription Printer Marks 50th Hospital Installation Milestone 2Apnex Medical, Inc. Raises Additional $14 Million 2Apnex Medical, Inc. Raises Additional $14 Million 3Surgical Hospital of Oklahoma to Partner with Surgical Care Affiliates 56221 1Surgical Hospital of Oklahoma to Partner with Surgical Care Affiliates 56221 2Amylin Pharmaceuticals to Present at Morgan Stanley Global Healthcare Unplugged Conference 13851 1BioSpecifics Technologies Corp Announces XIAFLEX 28TM 29 CORD I Study Published in New England Journal of Medicine 4941 1BioSpecifics Technologies Corp Announces XIAFLEX 28TM 29 CORD I Study Published in New England Journal of Medicine 4941 2